HomeCompareFOCIF vs JNJ

FOCIF vs JNJ: Dividend Comparison 2026

FOCIF yields 2.10% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FOCIF wins by $1.67M in total portfolio value
10 years
FOCIF
FOCIF
● Live price
2.10%
Share price
$2.67
Annual div
$0.06
5Y div CAGR
74.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.69M
Annual income
$1,253,743.96
Full FOCIF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FOCIF vs JNJ

📍 FOCIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFOCIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FOCIF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FOCIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FOCIF
Annual income on $10K today (after 15% tax)
$178.75/yr
After 10yr DRIP, annual income (after tax)
$1,065,682.37/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FOCIF beats the other by $1,064,978.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FOCIF + JNJ for your $10,000?

FOCIF: 50%JNJ: 50%
100% JNJ50/50100% FOCIF
Portfolio after 10yr
$857.1K
Annual income
$627,285.87/yr
Blended yield
73.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FOCIF
No analyst data
Altman Z
4.0
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FOCIF buys
0
JNJ buys
0
No recent congressional trades found for FOCIF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFOCIFJNJ
Forward yield2.10%3.36%
Annual dividend / share$0.06$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR74.8%5.8%
Portfolio after 10y$1.69M$20.0K
Annual income after 10y$1,253,743.96$827.78
Total dividends collected$1.63M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FOCIF vs JNJ ($10,000, DRIP)

YearFOCIF PortfolioFOCIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,068$367.59$10,676$355.77+$392.00FOCIF
2$12,507$664.62$11,407$389.39+$1.1KFOCIF
3$14,609$1,226.96$12,198$426.53+$2.4KFOCIF
4$17,973$2,341.37$13,056$467.62+$4.9KFOCIF
5$23,937$4,705.73$13,987$513.12+$9.9KFOCIF
6$35,851$10,238.32$14,998$563.56+$20.9KFOCIF
7$63,411$25,050.44$16,098$619.52+$47.3KFOCIF
8$140,233$72,382.79$17,295$681.69+$122.9KFOCIF
9$411,552$261,502.77$18,599$750.82+$393.0KFOCIF
10$1,694,104$1,253,743.96$20,022$827.78+$1.67MFOCIF

FOCIF vs JNJ: Complete Analysis 2026

FOCIFStock

Focusrite plc develops and markets hardware and software products primarily for audio professionals and amateur musicians in North America, Europe, the Middle East, Africa, and internationally. It operates through Focusrite, Focusrite Pro, Novation, ADAM Audio, Martin Audio, and Sequential segments. The company provides audio interface and other products for musicians under the Focusrite and Focusrite Pro brands; and products that are used in the creation of electronic music using synthesisers, grooveboxes, controllers, and software and apps under the Novation and Ampify brands. It also manufactures and distributes professional monitoring and loudspeaker technology under the ADAM Audio brand; performance ready systems for auditoriums under the Martin Audio brand; and analogue synthesizers under the Sequential brand. The company sells its products through distributors, retailers, and system integrators, as well as directly to end users through its e-commerce platform and in-app software. Focusrite plc was founded in 1985 and is headquartered in High Wycombe, the United Kingdom.

Full FOCIF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FOCIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FOCIF vs SCHDFOCIF vs JEPIFOCIF vs OFOCIF vs KOFOCIF vs MAINFOCIF vs ABBVFOCIF vs MRKFOCIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.